|
| Press Releases |
|
 |
|
| Tuesday, October 24, 2017 |
|
|
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar |
| SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market. more info >> |
|
| Tuesday, August 15, 2017 |
|
|
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances |
| Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications. more info >> |
|
| Thursday, June 15, 2017 |
|
|
First-Year Performance of Global Systematic Multi-Strategy Fund |
| The Board of Directors of Singapore eDevelopment Ltd ("SeD") wishes to announce that its Global Systematic Multi-Strategy Fund ("GSMS Fund") managed by Hengfai Asset Management Pte Ltd ("HFAM"), a wholly owned subsidiary of SeD's investment-arm SeD Capital Pte Ltd, achieved a gross and net return of 15% and 10%, respectively, in its first year of operation. more info >> |
|
| Monday, May 22, 2017 |
|
|
Singapore eDevelopment's Global BioLife Initiates Research on New Universal Drug Platform |
| Singapore eDevelopment Ltd ("SeD"), through its subsidiary Global BioLife Inc. ("Global BioLife"), has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. The research will be led by two-time Nobel Prize nominee, Mr Daryl Thompson. more info >> |
|
|
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform |
| Singapore eDevelopment Limited ("SeD") subsidiary Global BioLife Inc. has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
U.S. Marine Corps Selects GA-ASI for MUX TACAIR Collaborative Combat Aircraft Program
Feb 11, 2026 15:32 HKT/SGT
|
|
|
Changing Your Dog's Diet May Help the Planet More Than Changing Your Own, Study Finds
Feb 11, 2026 15:31 HKT/SGT
|
|
|
CleverTap Recognized as a Leader in Latest Gartner Magic Quadrant for Personalization Engines
Feb 11, 2026 14:30 HKT/SGT
|
|
|
研究發現：改變愛犬飲食對地球的助益可能大於改變自身飲食
Feb 11, 2026 12:42 HKT/SGT
|
|
|
The 18th Annual Global CSR & ESG Summit & Awards 2026 Arrives in Bangkok -- Igniting Asia with AI, Energy & ESG Innovation on 23 April 2026
Feb 11, 2026 11:39 HKT/SGT
|
|
|
美國海軍陸戰隊選定通用原子航空系統公司參與MUX TACAIR協同作戰戰機計畫
Feb 11, 2026 08:00 HKT/SGT
|
|
|
美国海军陆战队选定通用原子航空系统公司参与MUX战术空中作战系统联合战斗机项目
Feb 11, 2026 08:00 HKT/SGT
|
|
|
研究发现：改变爱犬饮食对地球的益处可能大于改变自身饮食
Feb 11, 2026 07:00 HKT/SGT
|
|
|
Kincora and AngloGold Ashanti Exploration Expands and Upgrades Nevertire with Drilling Recommenced
Feb 10, 2026 19:29 HKT/SGT
|
|
|
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong
Feb 10, 2026 18:14 HKT/SGT
|
|
|
億勝生物參展香港2026年亞太眼科學會年會（APAO 2026）强化眼科創新承諾
Feb 10, 2026 17:52 HKT/SGT
|
|
|
亿胜生物参展香港2026年亚太眼科学会年会（APAO 2026）强化眼科创新承诺
Feb 10, 2026 17:32 HKT/SGT
|
|
|
Honda Works Partner Aston Martin Aramco Formula One(TM) Team Unveils Livery of "AMR26" F1(TM) Machine Equipped with Honda Power Unit Ahead of the 2026 Race Season
Feb 10, 2026 18:25 JST
|
|
|
CTF Life+ Announces Winners of Financial Empowerment Case Competition, Innovative Platform Advances Intergenerational Inclusion
Feb 10, 2026 17:02 HKT/SGT
|
|
|
Honda to Make Organizational Changes to Further Enhance Competitiveness its Motorcycle, Automobile and Power Products Business
Feb 10, 2026 17:53 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
